Defining the ideal tumor marker for prostate cancer

Urol Clin North Am. 1997 May;24(2):247-52. doi: 10.1016/s0094-0143(05)70369-4.


The ideal tumor marker would function well for detection, screening, staging, prognosis, follow-up, and performance characteristics. Prostate-specific antigen is a remarkably good tool in this respect; however, the translation into improved patient outcomes is still uncertain.

MeSH terms

  • Biomarkers, Tumor / analysis*
  • Humans
  • Male
  • Prognosis
  • Prostate-Specific Antigen / analysis
  • Prostatic Neoplasms / diagnosis*
  • Sensitivity and Specificity


  • Biomarkers, Tumor
  • Prostate-Specific Antigen